2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
37
Prostatic Neoplasms
12
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Liver Neoplasms
3
Fibrosis
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Intraductal, Noninfiltrating
3
Uterine Cervical Neoplasms
2
Thyroid Nodule
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Neoplasms
2
Mouth Neoplasms
2
Lymphoma
2
Lymphedema
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammatory Breast Neoplasms
2
Infertility
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Interventions
Dexamethasone
3
iniparib
2
Ultrasonography
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Calcium Dobesilate
2
Blood Specimen Collection
2
tislelizumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
asparaginase erwinia chrysanthemi recombinant
1
amminedichloro(2-methylpyridine)platinum(II)
1
ZD4054
1
Vincristine
1
Sodium Chloride
1
Rituximab
1
Paclitaxel
1
Narrow Band Imaging
1
Methotrexate
1
Mammography
1
Lenalidomide
1
Immune Checkpoint Inhibitors
1
High-Energy Shock Waves
1
Doxorubicin
1
Dexrazoxane
1
Cytarabine
1
Cetirizine
1
Carboplatin
1
BNT162 Vaccine
1
Asparaginase
1
2019-nCoV Vaccine mRNA-1273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypersensitivity
×
High-Energy Shock Waves
×
Clear all
NCT02834585
2016-07-15
MUSTT
University of Genova
Unknown
70 enrolled